Dupont Jakob bought PYXS
August 20, 2026 · Form 4 insider transaction
Dupont Jakob bought 46,000 shares of Pyxis Oncology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
46,000
Price
$0.00
Total value
N/A
InsiderDupont Jakob
RoleDirector
CompanyPyxis Oncology, Inc. (PYXS)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateAugust 20, 2026
Filing dateAugust 20, 2026
Shares owned after46,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to this option will vest in equal monthly installments through October 31, 2026, subject to the reporting person's continued service through the applicable vesting date.